Literature DB >> 21708052

Neuropeptide S alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: a genetic animal model of depression.

Gregers Wegener1, Beate C Finger2, Betina Elfving1, Kirsten Keller1, Nico Liebenberg1, Christina W Fischer1, Nicolas Singewald3, David A Slattery4, Inga D Neumann4, Aleksander A Mathé5.   

Abstract

Neuropeptide S (NPS) and its receptor (NPSR) have been implicated in the mediation of anxiolytic-like behaviour in rodents. However, little knowledge is available regarding the NPS system in depression-related behaviours, and whether NPS also exerts anxiolytic effects in an animal model of psychopathology. Therefore, the aim of this work was to characterize the effects of NPS on depression- and anxiety-related parameters, using male and female rats in a well-validated animal model of depression: the Flinders Sensitive Line (FSL), their controls, the Flinders Resistant Line (FRL), and Sprague-Dawley (SD) rats. We found that FSL showed greater immobility in the forced swim test (FST) than FRL, confirming their phenotype. However, NPS did not affect depression-related behaviour in any rat line. No significant differences in baseline anxiety levels between the FSL and FRL strains were observed, but FSL and FRL rats displayed less anxiety-like behaviour compared to SD rats. NPS decreased anxiety-like behaviour on the elevated plus-maze in all strains. The expression of the NPSR in the amygdala, periventricular hypothalamic nucleus, and hippocampus was equal in all male strains, although a trend towards reduced expression within the amygdala was observed in FSL rats compared to SD rats. In conclusion, NPS had a marked anxiolytic effect in FSL, FRL and SD rats, but did not modify the depression-related behaviour in any strain, in spite of the significant differences in innate level between the strains. These findings suggest that NPS specifically modifies anxiety behaviour but cannot overcome/reverse a genetically mediated depression phenotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21708052     DOI: 10.1017/S1461145711000678

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  19 in total

1.  Neuropeptide S Induces Acute Anxiolysis by Phospholipase C-Dependent Signaling within the Medial Amygdala.

Authors:  Thomas Grund; Inga D Neumann
Journal:  Neuropsychopharmacology       Date:  2017-08-14       Impact factor: 7.853

Review 2.  Nuance and behavioral cogency: How the Visible Burrow System inspired the Stress-Alternatives Model and conceptualization of the continuum of anxiety.

Authors:  James M Robertson; Melissa A Prince; Justin K Achua; Russ E Carpenter; David H Arendt; Justin P Smith; Torrie L Summers; Tangi R Summers; Cliff H Summers
Journal:  Physiol Behav       Date:  2015-07-01

3.  Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide S receptor activity.

Authors:  David A Slattery; Roshan R Naik; Thomas Grund; Yi-Chun Yen; Simone B Sartori; Andrea Füchsl; Beate C Finger; Betina Elfving; Uwe Nordemann; Remo Guerrini; Girolamo Calo; Gregers Wegener; Aleksander A Mathé; Nicolas Singewald; Ludwig Czibere; Rainer Landgraf; Inga D Neumann
Journal:  J Neurosci       Date:  2015-03-18       Impact factor: 6.167

4.  Modification of caffeine effects on the affect-modulated startle by neuropeptide S receptor gene variation.

Authors:  Katharina Domschke; Benedikt Klauke; Bernward Winter; Agnes Gajewska; Martin J Herrmann; Bodo Warrings; Andreas Mühlberger; Katherina Wosnitza; Andrea Dlugos; Swantje Naunin; Kathrin Nienhaus; Manfred Fobker; Christian Jacob; Volker Arolt; Paul Pauli; Andreas Reif; Peter Zwanzger; Jürgen Deckert
Journal:  Psychopharmacology (Berl)       Date:  2012-03-08       Impact factor: 4.530

5.  Relationship of Neuropeptide S with Clinical and Metabolic Parameters of Patients during Rehabilitation Therapy for Schizophrenia.

Authors:  Agnieszka Markiewicz-Gospodarek; Renata Markiewicz; Beata Dobrowolska; Ryszard Maciejewski; Bartosz Łoza
Journal:  Brain Sci       Date:  2022-06-11

6.  Adipocytokine signaling is altered in Flinders sensitive line rats, and adiponectin correlates in humans with some symptoms of depression.

Authors:  Clare J Wilhelm; Dongseok Choi; Marilyn Huckans; Laura Manthe; Jennifer M Loftis
Journal:  Pharmacol Biochem Behav       Date:  2012-11-12       Impact factor: 3.533

Review 7.  Amygdala, neuropeptides, and chronic pain-related affective behaviors.

Authors:  Volker Neugebauer; Mariacristina Mazzitelli; Bryce Cragg; Guangchen Ji; Edita Navratilova; Frank Porreca
Journal:  Neuropharmacology       Date:  2020-03-15       Impact factor: 5.250

8.  Plasma Neuropeptide-S Levels in Populations Diagnosed with Generalized Anxiety Disorder: A Controlled Study.

Authors:  Hayriye Baykan; Özgür Baykan; Onur Durmaz; Hayrettin Kara; Adnan Adil Hişmioğullari; Tunay Karlidere
Journal:  Noro Psikiyatr Ars       Date:  2018-04-20       Impact factor: 1.339

Review 9.  Pharmacology, Physiology and Genetics of the Neuropeptide S System.

Authors:  Rainer K Reinscheid; Chiara Ruzza
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-23

10.  Neuropeptide S- and Neuropeptide S receptor-expressing neuron populations in the human pons.

Authors:  Csaba Adori; Swapnali Barde; Nenad Bogdanovic; Mathias Uhlén; Rainer R Reinscheid; Gabor G Kovacs; Tomas Hökfelt
Journal:  Front Neuroanat       Date:  2015-09-25       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.